You are here

FDA Authorizes First-of-its-kind Low-cost Ventilator Developed by University of Minnesota

U of M researchers developed and designed the Coventor as an alternative for clinical settings with a significant surge in patients or with few to no ventilators.

The U.S. Food and Drug Administration (FDA) today authorized the production and use of a low-cost ventilator first conceived by a team of University of Minnesota researchers and an alumnus. Known as the Coventor, this ventilator is the first-of-its-kind authorized for use under the FDA's Emergency Use Authorization for the COVID-19 outbreak.  Read full story

Share this post